Noretreat...I do not want you to be correct! This is ridicules....the good Doctors should be grateful to all investors whom have made it easier for the science and the doctors to follow their dreams. I truly believe a professional PR officer should be added to their Board . I am not saying I do not believe enough in this Company to question it. No no....I believe the science ...but I must say, the investors are not at all considered in their quest for success. I am sorry, but this is how I feel at this time. . Canada and the world is under attack...Isis is cutting people's head off...disease is killing thousands... I only want NNVC to take care of all aspects of their Company.
Zmapp, for instance "is the culmination of more than a decade of effort between government and industry partners" per 2012 PR about preclinical results, and they still haven't run any Phase I safety studies.
Zmapp is a promising drug in very short supply. It may not work well if the 3 antibodies' targets on the Ebola virus are mutating.
TKM-Ebola has been in development since at least 2005, when Protiva (Tekmira bought them in 2008) got a grant from USAMRIID to develop RNAi against filoviruses, and recently was put on hold in Phase I for safety concerns (immune reaction).
Expecting immediate results for EbolaCide2 is not very realistic, compared to the 10 years+ for development each for two of the farther-along Ebola drugs.
So yes, we have to wait for EbolaCide2 development. 3 months to go from conceptualization to animal testing would be rather miraculous in the overall scheme of things. They were able to quickly develop a drug ready for MERS testing in a BSL lab within a year or so. Rawnoc, what is your daily count at now for EbolaCide 2? Seymour said they *should* have it ready for internal validation within 30 days. I'm looking forward to an update "soon" (but I've been patiently waiting for lots of updates "soon" for a while!).
NNVC did not announce that FluCide *would* be delayed by EbolaCide2. They said it *could* be delayed, if EbolaCide2 showed excellent preclinical results and the world was desperate for a solution.
I'd rather they made faster and steadier progress on FluCide, but I guess doing a little MERSCide or EbolaCide2 development could be beneficial if those viruses become bigger problems, as some suspect they might.
You guys and gals should listen to Noretreat. I think he's a lot better trader/investor than most retail investors on this board. You can fool some of the people all the time......
News 
Market Data 
Discover 
